| Product Code: ETC9548330 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Angioedema Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Angioedema Market - Industry Life Cycle |
3.4 Sweden Angioedema Market - Porter's Five Forces |
3.5 Sweden Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Sweden Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Sweden Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Sweden Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Sweden Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Sweden Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Sweden Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of angioedema in Sweden |
4.2.2 Advances in treatment options and therapies for angioedema |
4.2.3 Growing investment in research and development for new treatments |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for angioedema treatment |
4.3.2 High cost of advanced treatment options for angioedema patients |
4.3.3 Lack of reimbursement options for certain angioedema therapies |
5 Sweden Angioedema Market Trends |
6 Sweden Angioedema Market, By Types |
6.1 Sweden Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Sweden Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Sweden Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Sweden Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Sweden Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Sweden Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Sweden Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Sweden Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Sweden Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Sweden Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Sweden Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Sweden Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Sweden Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Sweden Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Sweden Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Sweden Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Sweden Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Sweden Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Sweden Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Sweden Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Sweden Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Sweden Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Sweden Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Sweden Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Sweden Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Sweden Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Sweden Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Sweden Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Sweden Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Sweden Angioedema Market Import-Export Trade Statistics |
7.1 Sweden Angioedema Market Export to Major Countries |
7.2 Sweden Angioedema Market Imports from Major Countries |
8 Sweden Angioedema Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed treatment plans |
8.2 Average time from symptom onset to treatment initiation |
8.3 Rate of hospital readmissions for angioedema patients |
9 Sweden Angioedema Market - Opportunity Assessment |
9.1 Sweden Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Sweden Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Sweden Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Sweden Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Sweden Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Sweden Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Sweden Angioedema Market - Competitive Landscape |
10.1 Sweden Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Sweden Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here